New perspectives for synergy research with the "omic"-technologies

Phytomedicine

Volumn 16, Issue 6-7, 2009, Pages 495-508

  Ulrich Merzenich, G ^a   Panek, D ^a   Zeitler, H ^a   Wagner, H ^b   Vetter, H ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Co medication; Omic technology; Signal cascades; Synergy

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ASCORBIC ACID; COLESTIPOL; CURCUMA LONGA EXTRACT; CYCLOSPORIN; CYCLOSPORIN A; DAIDZEIN; DICLOFENAC; ETHINYLESTRADIOL; GINKGO BILOBA EXTRACT; HERBACEOUS AGENT; HYPERFORIN; HYPERICUM PERFORATUM EXTRACT; ISPAGULA; KNEIIP; MAGNOLIA OFFICINALIS EXTRACT; MERCAPTOPURINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PLANT EXTRACT; QUERCETIN; SCUTELLARIA BAICALENSIS EXTRACT; SILYBUM MARIANUM EXTRACT; TAXUS BREVIFOLIA EXTRACT; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; URTICA EXTRACT; VISCUM ALBUM EXTRACT;

ABSENCE OF SIDE EFFECTS; ARTHRITIS; BREAST CANCER; BREAST CARCINOMA; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INHIBITION; DRUG POTENCY; DRUG POTENTIATION; DRUG SAFETY; DRUG TARGETING; DRUG WITHDRAWAL; ERYTHEMA; GRAVES DISEASE; HUMAN; HYPERLIPOPROTEINEMIA; LOW DRUG DOSE; LUNG NON SMALL CELL CANCER; MELANOMA; NEOPLASM; NONHUMAN; OVARY CANCER; PAIN; PHYTOCHEMISTRY; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; STANDARDIZATION; STOMACH LESION; TOXICITY TESTING; UNSPECIFIED SIDE EFFECT;

DRUG THERAPY; GENOMICS; PLANT EXTRACTS; PROTEOMICS;

EID: 65549128097     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2009.04.001     Document Type: Review

References (73)

1. Ali R.E., and Rattan S.I. Curcumin's biphasic hormetic response on proteasome activity and heat-shock protein synthesis in human keratinocytes. Ann. N. Y. Acad. Sci. 1067 (2006) 394-399
2. Arab S., and Liu P.P. Heart failure in the post-genomics era: gene-environment interactions. Curr. Opin. Mol. Ther. 7 6 (2005) 577-582
3. Augustin M., Bock P.R., Hanisch J., Karasmann M., and Schneider B. Sicherheit und Wirksamkeit der komplementären Langzeitbehandlung von primären malignen Melanomen mit mittlerem bis hohem Risiko (UICC/AJCC-Stadium II und III) mittels standardisiertem fermentierten Mistelextrakt (Viscum album L.). Arzneim.-Forsch./Drug Res. 55 1 (2005) 38-49
4. Baxevanis, A.D., 2006. The importance of biological databases in biological discovery. Curr. Protoc. Bioinform. Chapter 1: Unit 1.1.
5. Becker J.C., et al. Gastroprotection by vitamin C - a heme-oxgenase-1-dependent mechanism?. Biochem. Biophys. Res. Commun. 312 (2003) 507-512
6. Berenbaum M. What is synergy?. Pharmacol. Rev. 41 (1989) 93-141
7. Bilello J.A. The agony and ecstasy of "OMIC" technologies in drug development. Curr. Mol. Med. 5 1 (2005) 39-52
8. Bock P.R., Friedel W.E., Hanisch J., Karasmann M., and Schneider B. Wirksamkeit und Sicherheit der komplemetären Langzeitbehandlung mit einem standardisiertem Extrakt aus Europäischer Mistel (Visucm album L.) zusätzlich zur konventionellen adjuvanten onkologischen Therapie bei primärem, nicht metastasiertem Mammakarzinom. Arznei.-Forsch./Drug Res. 54 8 (2004) 456-466
9. Brock, F.E., Uehleke, B., Wöhling, H., 2001. In: Schilcher, H., Kammerer, S., Wegner, T. (Eds.), Leitfaden Phytotherapie, Hyperlipoproteinämie, Psyllii semen. Elsevier, München, 2007, pp. 626-627. Pharma. Pharmacol. Lett. 2, 68-71.
10. Cannon G.W., and Ward J.R. Cytotoxic drugs and combination drug therapy. In: McCarty D.J., and Koopman W.J. (Eds). Arthritis and Allied Condititions. 12th ed (1993), Lea & Febinger, Philadelphia 646-665
11. Chan W.H., and Hsuuw Y.D. Dosage effects of ginkgolide B on ethanol-induced cell death in human hepatoma G2 cells. Ann. N. Y. Acad. Sci. 1095 (2007) 388-398
12. Cheok M.H., Yang W., Pui C.H., Downing J.R., Cheng C., Naeve C.W., Relling M.V., and Evans W.E. Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells. Nat. Genet. 34 (2003) 85-90
13. Chrubasik S., Enderlein W., Bauer R., and Grabner W. Evidence for antirheumatic effectiveness of stewed herba Urticae dioicae in acute arthritis: a pilot study. Phytomedicine 4 (1997) 105-108
14. Chrubasik S. Schmerztherapie mit Phytopharmaka. Der Gynäkologe 33 (2000) 59-65
15. Dallas C., Gerbi A., Guillaume T., Juchaux F., and Bernard F.X. Lipolytic effect of a polyphenolic citrus dry extract of red orange, grapefruit, orange (SINETROL) in human body fat adipocytes. Mechanism of action by inhibition of camp-phosphodiesterase (PDE). Phytomedicine 15 (2008) 783-792
16. Dang Z., and Löwik C.W. The balance between concurrent activation of ERs and PPARs determines daidzein-induced osteogenesis and adipogenesis. J. Bone. Miner. Res. 19 5 (2004) 853-861
17. Dammann H.G., Saleki M., Torz M., Schulz H.U., Krupp S., Schürer M., Timm J., and Gessner U. Effects o buffered and plain acetylsalicyclic acid formulations with and without ascorbic acid on gastric mucosa in healthy subjects. Aliment. Pharmacol. Ther. 19 3 (2004) 367-374
18. Dardano A., Ballardin M., Ferdeghini M., Lazzeri E., Traino C., Caraccio N., Mariani G., Barale R., and Monzani F. Anticlastogenic effect of Ginkgo biloba extract in Graves' disease patients receiving radioiodine therapy. J. Clin. Endocrinol. Metab. 92 (2007) 4286-4289
19. Ernst E. St John's Wort supplements endanger the success of organ transplantation. Arch. Surg. 137 (2002) 316-319
20. Ferraccioli G., De Santis M., and Tolusso B. Pharmacogenetics/pharmacogenomics and antirheumatic drugs in rheumatology. Pharmacogenomics 5 8 (2004) 1107-1116
21. Fiehn C. The future of folic acid antagonist therapy in rheumatoid arthritis. Arth. Rheum. 1 (2009) 1-4
22. Franklin M., Hafizi S., Reed A., Hockney R., and Murck H. Effect of sub-chronic treatment with Jarsin (extract of St. John's wort, Hypericum perforatum) at two dose levels on evening salivary melatonin and cortisol concentrations in healthy male volunteers. Pharmacopsychiatry 39 1 (2006) 13-15
23. Ganesh S., et al. Rationale and study design of the CardioGene Study: genomics if in-stent restenosis. Pharmacogenomics 5 7 (2004) 952-966
24. Gröber U. Arzneimittel und Mikronähstoffe. Medikationsorientierte Supplementierung (2007), Wissenschaftliche Verlagsgesellschaft mbH Stuttgart, Germany
25. Heilker R., Wolff M., Tautermann C.S., and Bieler M. G-protein coupled receptor-focused drug discovery using a target class platform approach. Drug. Discov. Today 14 4-5 (2009) 231-240
26. Hemaiswarya S., Kruthiventi A.K., and Doble M. Synergism between natural products and antibiotics against infectious diseases. Phytomedicine 15 8 (2008) 639-652
27. Imming P., Sinning Ch., and Meyer A. Drugs, their targets and the nature and number of drug targets. Drug Discov. 5 (2006) 821-834
28. Karin M. Inflammation-activated protein kinases as targets for drug development. Proc. Am. Thorac. Soc. 2 (2005) 386-390
29. Katz S., Harris R., Lau J.T., and Chau A. The use of gene expression analysis of proteomic databases in the development of a screening system to determine the value of natural medicinal products. Evid. Based Complement. Alternat. Med. 3 1 (2006) 65-70
30. Klenø T.G., Kiehr B., Baunsgaard D., and Sidelmann U.G. Combination of "omics" data to investigate the mechanism(s) of hydrazine-induced hepatotoxicity in rats and to identify potential biomarkers. Biomarkers 9 2 (2004) 116-138
31. Klippel J. Winning the battle, losing the war? Another editorial about rheumatoid arthritis. J. Rheum. 17 9 (1990) 1118-1122
32. Kober M., Pohl K., and Efferth H. Molecular mechanisms underlying St. John's Wort drug interaction. Curr. Drug Metab. 9 10 (2008) 1027-1037
33. Konturek P.K., Kania J., Gessner U., Konturek S.J., Hahn E.G., and Konturek J.W. Effect of vitamin C-related acetylsalicyclic acid on gastric mucosal damage before and after Helicobacter pylori therapy. Eur. J. Pharmacol. 15,506 2 (2004) 169-177
34. Linde K., Berner M.M., and Kriston L. St. John's Wort for major depression. Cochrane Database Syst. Rev. 8 4 (2008) CD00048
35. Mattes W.B., Petti S.D., Sansone S.A., Bushel P.R., and Waters M.D. Database development in toxidogenomics: issues and efforts. Environ. Health Perspect. 112 4 (2004) 495-505
36. Mayr M., Mayr U., Chung Y.L., Yin X., Griffiths J.R., and Yu Q. Vascular proteomics: linking proteomic and metabolomic changes. Proteomics 4 (2004) 3751-3761
37. Mueller S.C., Majcher-Peszynska J., Mundkowski R.G., Uehleke B., Klammt S., Sievers H., Lehnfeld R., Frank B., Thurow K., Kundt G., and Drewelow B. No clinically relevant CYP3A induction after St. John's Wort with low hyperforin content in healthy volunteers. Eur. J. Clin. Pharmacol. 65 1 (2009) 81-87
38. Nahrstedt A., Schmidt M., Jäggi R., Metz J., and Khayyal T. Willow bark extract: the contribution of polyphenols to the overall effects. Wien. Med. Wochenschr. 157 13-14 (2007) 348-351
39. Pakalapati, G., Li, L., Gretz, N., Koch, E., Wink, M., 2009. Influence of red clover (Trifolium pratense) Isoflavones on gene and protein expression profiles in liver of ovariectomized rats. Phytomedicine, in press, doi:10.1016/j.phymed.2009.03.003.
40. Pincus T., Yazici Y., Sokka T., Aletaha D., and Smolen J.S. Methotrexate as the "anchor drug" for the treatment of early rheumatoid arthritis. Clin. Exp. Rheumatol. 31 (2003) S179-S185
41. Rahimi R., Nikfar S., and Abdollahi M. Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: a meta-analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry 33 1 (2009) 118-127
42. Rochfort S. Metabolomics reviewed: a new "omics" platform technology for system biology and implications for natural products research. J. Nat. Prod. 68 12 (2005) 1813-1820
43. Sa G., and Das T. Anti cancer effects of curcumin: cycle of life and death. Cell Division 3 (2008) 1-14
44. Sagar S.M., Yance D., and Wong R.K. Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1. Curr. Oncol. 13 1 (2006) 14-26
45. Sagar S.M., Yance D., and Wong R.K. Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 2. Curr. Oncol. 13 3 (2006) 99-107
46. Schempp C.M., Winghofer B., Müller K., Schulte-Mönting J., Mannel M., Schöpf E., and Simon J.C. Effect of oral administration of Hypericum perforatum extract (St. John's Wort) on skin erythema and pigmentation induced by UVB, UVA, visible light and solar simulated radiation. Phytotherap. Res. 17 2 (2003) 141-146
47. Schierholz J.M., Piao B.K., Wang Y.X., Xie G.R., Mansmann U., Matthes H., Beuth J., and Lin H.S. Komplementäre Tumortherapie mit standardisiertem Mistelgesamtextrakt. Deutsche Z. f. Onkol. 35 (2003) 186-194
48. Searfoss G.H., Timothy P., Jolly R., and Jolly R.A. The role of transcriptome analysis in pre-clinical toxicology. Curr. Mol. Med. 5 (2004) 53-64
49. Searfoss G.H., Ryan T.P., and Jolly R.A. The role fo transcriptome analysis in pre-clinical toxicology. Curr. Mol. Med. 5 (2005) 53-64
50. Si H., and Liu D. Phytochemical genistein in the regulation of vascular function: new insights. Curr. Med. Chem. 14 24 (2007) 2581-2589
51. Solanky K.S., Bailey N.J., Beckwith-Hall B.M., Davis A., Bingham S., Holmes E., Nicholson J.K., and Cassidy A. Application of biofluid 1H nuclear magnetic resonance-based metabonic techniques for the analysis of the biochemical effects of dietary isoflavones on human plasma profile. Anal. Biochem. 323 (2003) 197-204
52. Sood A., Sood R., Brinker F.J., Mann R., Loehrer L.L., and Wahner-Roedler D.L. Potential for interactions between dietary supplements and prescription medications. Am. J. Med. 121 3 (2008) 207-211
53. Spence, J.D., Huff, M.W., Heidenheim, P., Viswanatha, A., Munoz, C., Lindsay, R., Wolfe, B., Mills, D., 1995. Ann. Intern. Med. 123(7), 493-499.
54. Spencer J.P. Food for thought: the role of dietary flavonoids in enhancing memory, learning and neuro-cognitive performance. Proc. Nutr. Soc. 67 2 (2008) 238-252
55. Stafford P. Genomics, transcriptomics, and proteomics: novel detection technologies and drug discovery. In: Carmen A., and Hardiman G. (Eds). Biochips as Pathways to Drug Discovery (2007), CRC Press, Taylor & Francis Group, Boca Raton
56. St Clair E.W., van der Heijde D.M., Smolen J.S., Maini R.N., Bathon J.M., Emery P., Keystone E., Schiff M., Kalden J.R., Wang B., Dewoody K., Weiss R., and Baker D. Active-controlled study of patients receiving infliximab for the treatment of rheumatoid arthritis of early onset study group. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum. 50 11 (2004) 3432-3443
57. Storck T., Von Brevern M.C., Behrens C.K., Scheel J., and Bach A. Transcriptomics in predictive toxicology. Curr. Opin. Drug. Disc. Dev. 5. (2002) 90-97
58. Sucher N.J., and Carles M.C. Genome-based approaches to the authentication of medicinal plant. Planta Med. 74 6 (2008) 603-623
59. Suter L., Babiss L.E., and Wheeldon E.B. Toxicogenomics in predictive toxicology in drug development. Chem. Biol. 11 (2004) 161-171
60. Takahashi Y., Lagigne J.A., Hursting S.P., Chandramouli G.V., Perkins S.N., Kim Y.S., and Wang T.T. Molecular signature of soy-derived phytochemicals in androgen-responsive prostate cancer cells: a comparison study using DNA microarray. Mol. Carcinog. 45 12 (2006) 943-956
61. The Ayurvedic Formulary of India Part I, 1978. Government of India, Ministry of Health and Family Planning, Department of Health, Government of India Press, Faridabad.
62. Ulrich-Merzenich G., Zeitler H., Panek D., Bokemeyer D., and Vetter H. Vitamin C promotes human endothelial cell growth via ERK-signaling pathway. Eur. J. Nutr. 46 (2007) 87-94
63. Ulrich-Merzenich G., Zeitler H., Panek D., Vetter H., and Wagner H. Application of the "Omic"-technologies in phytomedicine. Phytomedicine 14 1 (2007) 70-82
64. Ulrich-Merzenich G., Jobst D., Zeitler H., Müller J., and Vetter H. Measurement of synergistic effects of a phytopharmaceutical by microarray-analysis. Planta Med. 73 (2007) SL026
65. Ulrich-Merzenich G., Zeitler H., Vetter H., and Kraft K. Synergy research: vitamins and secondary plant components in the maintenance of the redox-homeostasis and in cell signaling. Phytomedicine 16 1 (2009) 2-16
66. Vasu V.T., Hobson B., Gohil K., and Cross C.E. Genome-wide screening of alpha-tocopherol sensitive genes in heart tissue from alpha-tocopherol transfer protein null mice (ATTP(-/-)). FEBS Lett. 581 (2007) 1572-1578
67. Wagner H., and Ulrich-Merzenich G. Synergy research: approaching a new generation of phytopharmaceuticals. Part I. Phytomedicine 16 2-3 (2009) 97-107
68. Wagner H. Multitarget therapy-the future of treatment for more than just functional dyspepsia. Phytomedicine 13 Suppl. V (2006) 122-129
69. Wang Y., Tang H., Nicholson J.K., Hylands P.J., Sampson J., and Holmes E. A metabonic strategy for the detection of the metabolic of chamomile (Matricaria recutita L.) ingestion. J. Agric. Food Chem. 53 2 (2005) 191-196
70. Wenzel U., Herzog A., Kuntz S., and Daniel H. Protein expression profiling identifies molecular targets of quercetin as a major dietary flavonoid in human colon cancer cells. Proteomics 4 7 (2004) 2160-2174
71. Will-Shahab L., Bauer S., Kunter U., Roots I., and Brattström A. St John's Wort extract (Ze 117) does not alter the pharmacokinetics of a low-dose oral contraceptive. Eur. J. Clin. Pharmacol. 65 3 (2009) 287-294
72. Xu G.Z., Cai W.M., Qin D.X., et al. Chinese herb "destagnation" series I: combination of radiation with destagnation in the treatment of nasopharyngeal carcinoma: a prospective randomized trial on 188 cases. Int. J. Radiat. Oncol. Biol. Phys. 16 (1989) 297-300
73. Zimmerman H.J. Drug-induced liver disease. Clin. Liv. Dis. 4 1 (2000) 73-96